Patent Assignment
Reel/Frame 059548/0478
Assignment of Assignor's Interest
Recorded: 2022-04-08
Pages: 5
Assignor
HEITZMANN, MARKUS
Executed: 2015-03-16
Assignee
NOVARTIS PHARMA AG
POSTFACH, BASEL, 4002, SWITZERLAND
Covered Property
(1)
Selective Reduction of Cysteine Residues in Il-17 Antibodies
Application:
17/683,888 →
Publication:
US 2022/0315650
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 8, 2022
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 059548/0653 →
Assignment of Assignor's Interest
Apr 8, 2022
From: WINKLER, JOHANN
To: SANDOZ GMBH
Reel/Frame 059549/0077 →
Assignment of Assignor's Interest
Apr 8, 2022
From: SANDOZ GMBH
To: SANDOZ AG
Reel/Frame 059549/0262 →
Assignment of Assignor's Interest
Apr 8, 2022
From: SANDOZ AG
To: NOVARTIS AG
Reel/Frame 059549/0479 →
Assignment of Assignor's Interest
Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →